Global Targeted Resequencing Service Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Targeted Resequencing Service market size will reach US$ 3340 million by 2031.
Targeted Resequencing Service is a high-precision sequencing approach that focuses on specific genes, genomic regions, or functional elements of interest using next-generation sequencing (NGS) technologies. This service is widely used in disease-associated variant detection, pharmacogenomics, biomarker discovery, cancer profiling, and genetic screening. Target enrichment methods such as hybrid capture, PCR amplification, or CRISPR-based selection are used to isolate the regions of interest, followed by high-throughput sequencing and bioinformatics analysis. Compared to whole-genome or whole-exome sequencing, targeted resequencing offers smaller data volumes, lower costs, higher coverage depth, and greater sensitivity—making it ideal for identifying low-frequency mutations or analyzing specific genes across large sample sets. Target panels can be custom-designed to include dozens to thousands of genes, supporting both individual and multiplexed sample analysis. This service delivers efficient, cost-effective, and clinically meaningful insights, serving as a powerful tool for precision medicine and molecular diagnostics.
United States market for Targeted Resequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Targeted Resequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Targeted Resequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Targeted Resequencing Service players cover Eurofins Scientific, CosmosID, SoftGenetics, CD Genomics, HHU, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Targeted Resequencing Service Industry Forecast” looks at past sales and reviews total world Targeted Resequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Resequencing Service sales for 2025 through 2031. With Targeted Resequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Resequencing Service industry.
This Insight Report provides a comprehensive analysis of the global Targeted Resequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Resequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Resequencing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Resequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Resequencing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Resequencing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Targeted Resequencing Service
Research Targeted Resequencing Service
Others
Segmentation by Application:
Gene Mutation Detection
Pharmacogenomics
Biomarker Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Scientific
CosmosID
SoftGenetics
CD Genomics
HHU
Paragon Genomics
IGATech
Sistemas Genómicos
Macrogen
Illumina
Please note: The report will take approximately 2 business days to prepare and deliver.
Targeted Resequencing Service is a high-precision sequencing approach that focuses on specific genes, genomic regions, or functional elements of interest using next-generation sequencing (NGS) technologies. This service is widely used in disease-associated variant detection, pharmacogenomics, biomarker discovery, cancer profiling, and genetic screening. Target enrichment methods such as hybrid capture, PCR amplification, or CRISPR-based selection are used to isolate the regions of interest, followed by high-throughput sequencing and bioinformatics analysis. Compared to whole-genome or whole-exome sequencing, targeted resequencing offers smaller data volumes, lower costs, higher coverage depth, and greater sensitivity—making it ideal for identifying low-frequency mutations or analyzing specific genes across large sample sets. Target panels can be custom-designed to include dozens to thousands of genes, supporting both individual and multiplexed sample analysis. This service delivers efficient, cost-effective, and clinically meaningful insights, serving as a powerful tool for precision medicine and molecular diagnostics.
United States market for Targeted Resequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Targeted Resequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Targeted Resequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Targeted Resequencing Service players cover Eurofins Scientific, CosmosID, SoftGenetics, CD Genomics, HHU, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Targeted Resequencing Service Industry Forecast” looks at past sales and reviews total world Targeted Resequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Resequencing Service sales for 2025 through 2031. With Targeted Resequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Resequencing Service industry.
This Insight Report provides a comprehensive analysis of the global Targeted Resequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Resequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Resequencing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Resequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Resequencing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Resequencing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Targeted Resequencing Service
Research Targeted Resequencing Service
Others
Segmentation by Application:
Gene Mutation Detection
Pharmacogenomics
Biomarker Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Scientific
CosmosID
SoftGenetics
CD Genomics
HHU
Paragon Genomics
IGATech
Sistemas Genómicos
Macrogen
Illumina
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
83 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Targeted Resequencing Service Market Size by Player
- 4 Targeted Resequencing Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Targeted Resequencing Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
